| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.09 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |